| EGLNX | SPNNX | EGLNX / SPNNX | |
| Total Expense Ratio | 1.26 | 9.27 | 14% |
| Annual Report Gross Expense Ratio | 1.67 | 9.27 | 18% |
| Fund Existence | 7 years | 7 years | - |
| Gain YTD | 3.351 | 5.344 | 63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000000 | 1000 | 1,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 212M | 3.88B | 5% |
| Annual Yield % from dividends | 4.96 | 7.60 | 65% |
| Returns for 1 year | 3.94 | 5.71 | 69% |
| Returns for 3 years | 71.47 | 58.31 | 123% |
| Returns for 5 years | 236.70 | 180.27 | 131% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIOLX | 28.88 | 0.10 | +0.35% |
| Morgan Stanley Inst International Opp L | |||
| UBVUX | 78.41 | 0.18 | +0.23% |
| Undiscovered Managers Behavioral Val R4 | |||
| OILGX | 25.28 | 0.01 | +0.04% |
| Optimum Large Cap Growth Instl | |||
| SJGAX | 31.83 | N/A | N/A |
| Steward Large Cap Growth A | |||
| LYFCX | 15.64 | -0.10 | -0.64% |
| AlphaCentric Life Sciences & Hlthcare C | |||